2025 ASCO Annual Meeting: Focus on Pancreatic Cancer

Elraglusib With Gem/Nab-Paclitaxel for Previously Untreated Metastatic Pancreatic Cancer
Elraglusib With Gem/Nab-Paclitaxel for Previously Untreated Metastatic Pancreatic Cancer
Devalingam Mahalingam, PhDPancreatic Cancer | June 2, 2025
Dr. Mahalingam shares preliminary results from the randomized phase 2 study of elraglusib with gemcitabine/nab-paclitaxel.
Clinical Profile of Long-Term Survivors May Be Informative for Treatment in Metastatic Pancreatic Cancer
Clinical Profile of Long-Term Survivors May Be Informative for Treatment in Metastatic Pancreatic Cancer
Lauren Dembeck, PhDPancreatic Cancer | June 2, 2025
A post hoc analysis of the NAPOLI 3 trial offers insight into prolonged survival in mPDAC.
PANOVA-3 Shows Tumor-Treating Fields Extend Survival in Locally Advanced Pancreatic Cancer
PANOVA-3 Shows Tumor-Treating Fields Extend Survival in Locally Advanced Pancreatic Cancer
Lauren Dembeck, PhDPancreatic Cancer | June 2, 2025
A therapy has shown a statistically significant OS benefit in patients with unresectable locally advanced pancreatic cancer.
CASSANDRA Study May Set New Standard for Neoadjuvant Chemo for Resectable, Borderline Resectable PDAC
CASSANDRA Study May Set New Standard for Neoadjuvant Chemo for Resectable, Borderline Resectable PDAC
Zachary BessettePancreatic Cancer | June 2, 2025
Results of CASSANDRA may alter the standard of care for patients with resectable PDAC.
CASSANDRA: Neoadjuvant PAXG Versus mFOLFIRINOX for Resectable, Borderline Resectable PDAC
CASSANDRA: Neoadjuvant PAXG Versus mFOLFIRINOX for Resectable, Borderline Resectable PDAC
Michele Reni, MDPancreatic Cancer | June 1, 2025
Dr. Reni breaks a randomized phase III trial of pre-operative chemotherapy with mFOLFIRINOX or PAXG for stage I-III PDAC.
Claudin18.2-Targeted ADC Shows Safety and Efficacy in PDAC
Claudin18.2-Targeted ADC Shows Safety and Efficacy in PDAC
Lauren Dembeck, PhDPancreatic Cancer | May 29, 2025
The Claudin18.2 antibody-drug conjugate IBI343 is well tolerated and shows encouraging efficacy in patients with PDAC.
Advertisement
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About Column

    About Us

    Editorial Policy

    Advertising


    Contribute Column

    eNewsletters

    Contribute

    Our Network

    GU Oncology Now

    Lung Cancers Today

    Cancer Nursing Today

    DocWire News

    MashupMD

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |